Funded Tech Companies

Metabolex

Headquartered in Newark, Metabolex raised its funding from private investors, Merlin BioMed Group and Novo Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Metabolex, Inc. is a privately held pharmaceutical company dedicated to the discovery and development of drugs to treat diabetes and related metabolic disorders.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/3/2013

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Harold Wart

        

Chief Financial Officer

Sujal Shah

        

Chief Medical Officer

Pol Boudes

        

VP - Bus. Development

Patrick O'Mara

        

VP - R & D

Charles McWherter

        

Company Investors

• Merlin BioMed Group
• Novo Ventures
• Bay City Capital (Carl Goldfischer)
• VantagePoint Capital Partners
• Venrock (Anthony Evnin)
• Chart Venture Partners
• Birchmere Ventures
• Versant Ventures (Bradley Bolzon)
• Alta Partners (Edward Penhoet)
• Johnson & Johnson Development Corporation
• AllianceBernstein
• KBC Private Equity NV
• MPM Capital (Kurt von Emster)
• VantagePoint Capital Partners (Stephan Dolezalek)
• Venrock (Tony Evnin)
• KBC Securities
• CLS

Browse more funded tech companies:

Metabiota | Metabolic Solutions Development

Share this article

About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary